Pre-diagnosis and post-diagnosis dietary patterns and survival in women with ovarian cancer.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
02
03
2022
accepted:
16
06
2022
revised:
14
06
2022
pubmed:
28
6
2022
medline:
16
9
2022
entrez:
27
6
2022
Statut:
ppublish
Résumé
Evidence is limited on inflammation-related dietary patterns and mortality in ovarian cancer survivors. We examined the associations between pre- and post-diagnosis dietary patterns, including change in diet from before to after diagnosis, and mortality among 1003 ovarian cancer survivors in two prospective cohort studies. Dietary pattern scores for empirical dietary inflammatory pattern (EDIP) and Alternative Healthy Eating Index (AHEI) were calculated based on food frequency questionnaires. We used Cox proportional hazard models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for ovarian cancer-specific and all-cause mortality. Pre-diagnosis EDIP score and AHEI were not associated with mortality. Among non-high grade serous cases, a higher post-diagnosis EDIP score was associated with increased risk of all-cause mortality (HR Consuming a more inflammatory dietary pattern post-diagnosis was associated with increased mortality in ovarian cancer survivors, suggesting limiting the inflammatory potential of diet post-diagnosis could lead to enhanced survivorship.
Sections du résumé
BACKGROUND
Evidence is limited on inflammation-related dietary patterns and mortality in ovarian cancer survivors.
METHODS
We examined the associations between pre- and post-diagnosis dietary patterns, including change in diet from before to after diagnosis, and mortality among 1003 ovarian cancer survivors in two prospective cohort studies. Dietary pattern scores for empirical dietary inflammatory pattern (EDIP) and Alternative Healthy Eating Index (AHEI) were calculated based on food frequency questionnaires. We used Cox proportional hazard models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for ovarian cancer-specific and all-cause mortality.
RESULTS
Pre-diagnosis EDIP score and AHEI were not associated with mortality. Among non-high grade serous cases, a higher post-diagnosis EDIP score was associated with increased risk of all-cause mortality (HR
CONCLUSION
Consuming a more inflammatory dietary pattern post-diagnosis was associated with increased mortality in ovarian cancer survivors, suggesting limiting the inflammatory potential of diet post-diagnosis could lead to enhanced survivorship.
Identifiants
pubmed: 35760897
doi: 10.1038/s41416-022-01901-8
pii: 10.1038/s41416-022-01901-8
pmc: PMC9470575
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1097-1105Subventions
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians. 2018;68:394–424.
Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA: A Cancer J Clinicians. 2019;69:280–304.
Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9:55–55.
pubmed: 34233747
doi: 10.1186/s40364-021-00310-y
pmcid: 8261911
American Cancer Society. Cancer Facts & Figures 2021. Atlanta: American Cancer Society; 2021.
Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. JNCI 1999;91:1459–67.
pubmed: 10469746
doi: 10.1093/jnci/91.17.1459
Poole EM, Lee IM, Ridker PM, Buring JE, Hankinson SE, Tworoger SS. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. Am J Epidemiol. 2013;178:1256–64.
pubmed: 23966559
doi: 10.1093/aje/kwt098
pmcid: 3792725
Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, et al. High levels of C-reactive protein are associated with an increased risk of ovarian cancer: results from the ovarian cancer cohort consortium. Cancer Res. 2019;79:5442–51.
pubmed: 31462430
doi: 10.1158/0008-5472.CAN-19-1554
pmcid: 6801098
Savant, SS, Sriramkumar, S, O’Hagan, HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers (Basel). 2018;10.
Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008;14:710–4.
pubmed: 18245530
doi: 10.1158/1078-0432.CCR-07-1044
Yang Z, Gu JH, Guo CS, Li XH, Yang WC. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. Oncotarget.2017;8:46414–24.
pubmed: 28423365
doi: 10.18632/oncotarget.16793
pmcid: 5542277
Gao XP, Liu YH, Liu ZY, Wang LJ, Jing CX, Zhu S, et al. Pretreatment lymphocyte-to-monocyte ratio as a predictor of survival among patients with ovarian cancer: a meta-analysis. Cancer Manag Res. 2019;11:1907–20.
pubmed: 30881117
doi: 10.2147/CMAR.S184970
pmcid: 6398401
Galland L. Diet and inflammation. Nutr Clin Pr. 2010;25:634–40.
doi: 10.1177/0884533610385703
Thomson CA, Crane TE, Wertheim BC, Neuhouser ML, Li W, Snetselaar LG, et al. Diet quality and survival after ovarian cancer: results from the Women’s Health Initiative. J Natl Cancer Inst. 2014;106.
Peres LC, Hebert JR, Qin B, Guertin KA, Bandera EV, Shivappa N, et al. Prediagnostic proinflammatory dietary potential is associated with all-cause mortality among African-American women with high-grade serous ovarian carcinoma. J Nutr. 2019;149:1606–16.
pubmed: 31152675
doi: 10.1093/jn/nxz098
pmcid: 6735701
Nagle CM, Ibiebele T, Shivappa N, Hébert JR, DeFazio A, Webb PM. The association between the inflammatory potential of diet and risk of developing, and survival following, a diagnosis of ovarian cancer. Eur J Nutr. 2019;58:1747–56.
pubmed: 30027314
doi: 10.1007/s00394-018-1779-x
Al Ramadhani RM, Nagle CM, Ibiebele TI, Grant P, Friedlander M, DeFazio A, et al. Pre- and post-diagnosis diet quality and ovarian cancer survival. Cancer Epidemiol Biomark Prev. 2021;30:229–32.
doi: 10.1158/1055-9965.EPI-20-1036
Tabung FK, Smith-Warner SA, Chavarro JE, Wu K, Fuchs CS, Hu FB, et al. Development and validation of an empirical dietary inflammatory index. J Nutr. 2016;146:1560–70.
pubmed: 27358416
doi: 10.3945/jn.115.228718
pmcid: 4958288
Li SX, Hodge AM, MacInnis RJ, Bassett JK, Ueland PM, Midttun Ø, et al. Inflammation-related marker profiling of dietary patterns and all-cause mortality in the Melbourne Collaborative Cohort Study. J Nutr. 2021;151:2908–16.
pubmed: 34320210
doi: 10.1093/jn/nxab231
Colditz GA, Hankinson SE. The Nurses’ Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5:388–96.
pubmed: 15864280
doi: 10.1038/nrc1608
Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Spiegelman D, et al. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst. 1998;90:1155–60.
pubmed: 9701365
doi: 10.1093/jnci/90.15.1155
Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, et al. Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol. 2017;185:570–84.
pubmed: 28338828
doi: 10.1093/aje/kww104
pmcid: 5859994
Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, et al. Test of the national death index. Am J Epidemiol. 1984;119:837–9.
pubmed: 6720679
doi: 10.1093/oxfordjournals.aje.a113804
Tabung FK, Smith-Warner SA, Chavarro JE, Fung TT, Hu FB, Willett WC, et al. An empirical dietary inflammatory pattern score enhances prediction of circulating inflammatory biomarkers in adults. J Nutr. 2017;147:1567–77.
pubmed: 28659407
doi: 10.3945/jn.117.248377
pmcid: 5525108
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142:1009–18.
pubmed: 22513989
doi: 10.3945/jn.111.157222
pmcid: 3738221
Rhee JJ, Mattei J, Hughes MD, Hu FB, Willett WC. Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care. 2015;38:596–603.
pubmed: 25592193
doi: 10.2337/dc14-1986
pmcid: 4370327
Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, et al. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. Lancet Oncol. 2018;19:1107–16.
pubmed: 30029888
doi: 10.1016/S1470-2045(18)30373-5
pmcid: 6242286
Zhong X, Guo L, Zhang L, Li Y, He R, Cheng G. Inflammatory potential of diet and risk of cardiovascular disease or mortality: a meta-analysis. Sci Rep. 2017;7:6367.
pubmed: 28744020
doi: 10.1038/s41598-017-06455-x
pmcid: 5527022
Deng FE, Shivappa N, Tang Y, Mann JR, Hebert JR. Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III. Eur J Nutr. 2017;56:1085–93.
pubmed: 26825592
doi: 10.1007/s00394-016-1158-4
Garcia-Arellano A, Martínez-González MA, Ramallal R, Salas-Salvadó J, Hébert JR, Corella D, et al. Dietary inflammatory index and all-cause mortality in large cohorts: The SUN and PREDIMED studies. Clin Nutr. 2019;38:1221–31.
pubmed: 30651193
doi: 10.1016/j.clnu.2018.05.003
Tabung FK, Steck SE, Liese AD, Zhang J, Ma Y, Caan B, et al. Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women’s Health Initiative. Br J Cancer. 2016;114:1277–85.
pubmed: 27100730
doi: 10.1038/bjc.2016.98
pmcid: 4891517
Zucchetto A, Gini A, Shivappa N, Hébert JR, Stocco C, Dal Maso L, et al. Dietary inflammatory index and prostate cancer survival. Int J Cancer. 2016;139:2398–404.
pubmed: 27242333
doi: 10.1002/ijc.30208
pmcid: 5585016
Yuan C, Morales-Oyarvide V, Khalaf N, Perez K, Tabung FK, Ho GYF, et al. Prediagnostic inflammation and pancreatic cancer survival. J Natl Cancer Inst. 2021;113:1186–93.
pubmed: 33739411
doi: 10.1093/jnci/djab040
pmcid: 8522350
Playdon MC, Nagle CM, Ibiebele TI, Ferrucci LM, Protani MM, Carter J, et al. Pre-diagnosis diet and survival after a diagnosis of ovarian cancer. Br J Cancer. 2017;116:1627–37.
pubmed: 28463959
doi: 10.1038/bjc.2017.120
pmcid: 5518850
Nagle CM, Purdie DM, Webb PM, Green A, Harvey PW, Bain CJ. Dietary influences on survival after ovarian cancer. Int J Cancer. 2003;106:264–9.
pubmed: 12800204
doi: 10.1002/ijc.11204
Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, et al. Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer. J Am Diet Assoc. 2010;110:369–82.
pubmed: 20184987
doi: 10.1016/j.jada.2009.11.014
Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019;111:60–8.
pubmed: 29718305
doi: 10.1093/jnci/djy071
Kurman RJ, Shih Ie,M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol. 2011;42:918–31.
pubmed: 21683865
doi: 10.1016/j.humpath.2011.03.003
pmcid: 3148026
Wang T, Townsend MK, Simmons V, Terry KL, Matulonis UA, Tworoger SS. Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer. Int J Cancer. 2020;147:736–46.
pubmed: 31693173
doi: 10.1002/ijc.32773
Jeon SY, Go RE, Heo JR, Kim CW, Hwang KA, Choi KC. Effects of cigarette smoke extracts on the progression and metastasis of human ovarian cancer cells via regulating epithelial-mesenchymal transition. Reprod Toxicol. 2016;65:1–10.
pubmed: 27327412
doi: 10.1016/j.reprotox.2016.06.012
Kelemen LE, Warren GW, Koziak JM, Köbel M, Steed H. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer. Gynecol Oncol. 2016;140:124–30.
pubmed: 26549109
doi: 10.1016/j.ygyno.2015.11.008
Müezzinler A, Mons U, Gellert C, Schöttker B, Jansen E, Kee F, et al. Smoking and all-cause mortality in older adults: results from the CHANCES Consortium. Am J Prev Med. 2015;49:e53–63.
pubmed: 26188685
doi: 10.1016/j.amepre.2015.04.004
Maunsell E, Drolet M, Brisson J, Robert J, Deschênes L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol. 2002;20:1017–25.
pubmed: 11844825
doi: 10.1200/JCO.2002.20.4.1017
Salminen EK, Lagström HK, Heikkilä S, Salminen S. Does breast cancer change patients’ dietary habits? Eur J Clin Nutr. 2000;54:844–8.
pubmed: 11114679
doi: 10.1038/sj.ejcn.1601103
Harris HR, Bergkvist L, Wolk A. Folate intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Res Treat. 2012;132:243–50.
pubmed: 22037788
doi: 10.1007/s10549-011-1838-y
Tabung FK, Huang T, Giovannucci EL, Smith-Warner SA, Tworoger SS, Poole EM. The inflammatory potential of diet and ovarian cancer risk: results from two prospective cohort studies. Br J Cancer. 2017;117:907–11.
pubmed: 28772285
doi: 10.1038/bjc.2017.246
pmcid: 5589994
Lau TS, Chan LK, Wong EC, Hui CW, Sneddon K, Cheung TH, et al. A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR. Oncogene. 2017;36:3576–87.
pubmed: 28166193
doi: 10.1038/onc.2016.509
pmcid: 5485181
Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 2005;65:10355–62.
pubmed: 16288025
doi: 10.1158/0008-5472.CAN-05-0957
Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett. 2010;295:110–23.
pubmed: 20236757
doi: 10.1016/j.canlet.2010.02.019